Statement of retraction. Efficacy of two new asymmetric bispyridinium oximes (K-27 and K-48) in rats exposed to diisopropylfluorophosphate: comparison with pralidoxime, obidoxime, trimedoxime, methoxime, and HI-6.

Author unknown

Open source

DOI
10.1080/15376510802312365
Published
2009 Mar
Container
Clinical toxicology (Philadelphia, Pa.)
Publisher
Not recorded
Open access
no

Credibility signals

serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/15376510802312365,
  title = {Statement of retraction. Efficacy of two new asymmetric bispyridinium oximes (K-27 and K-48) in rats exposed to diisopropylfluorophosphate: comparison with pralidoxime, obidoxime, trimedoxime, methoxime, and HI-6.},
  year = {2009},
  journal = {Clinical toxicology (Philadelphia, Pa.)},
  doi = {10.1080/15376510802312365},
  url = {https://doi.org/10.1080/15376510802312365}
}

RIS

TY  - JOUR
TI  - Statement of retraction. Efficacy of two new asymmetric bispyridinium oximes (K-27 and K-48) in rats exposed to diisopropylfluorophosphate: comparison with pralidoxime, obidoxime, trimedoxime, methoxime, and HI-6.
PY  - 2009
JO  - Clinical toxicology (Philadelphia, Pa.)
DO  - 10.1080/15376510802312365
UR  - https://doi.org/10.1080/15376510802312365
ER  - 

APA

Statement of retraction. Efficacy of two new asymmetric bispyridinium oximes (K-27 and K-48) in rats exposed to diisopropylfluorophosphate: comparison with pralidoxime, obidoxime, trimedoxime, methoxime, and HI-6.. (2009). Clinical toxicology (Philadelphia, Pa.). https://doi.org/10.1080/15376510802312365

Source records